Spotlight on Japan
As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry. But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.
Article
The digital imperative for pharma companies in Japan
-
Five facts showing that companies should invest in digital customer engagement in Japan.
Article
The medtech opportunity for Japanese companies
-
A large-scale commitment to growth in healthcare technologies could be a key contributor to the Japanese economy.
Article
Elevating the impact of medical affairs in Japan
-
Recent research sheds light on the value of the medical channel and what it takes to have a high-performing medical-affairs organization.